.Basilea Pharmaceutica's work developing brand new antifungals has actually gotten a notable increas...
.Possessing presently gathered up the united state legal rights to Capricor Therapies' late-stage Du...
.After dismissing the decision date for Applied Therapeutics' metabolic problem medication govoresta...
.Novo Nordisk is continuing its press into genetic medicines, accepting compensate NanoVation Therap...
.Innovent Biologics has actually helped make the case that its gate inhibitor-cytokine fusion health...
.A period 3 test of Daiichi Sankyo and Merck & Co.'s HER3-directed antibody-drug conjugate (ADC) ...
.Five months after Rakovina Rehabs turned toward artificial intelligence, the cancer-focused biotech...
.Ascendis Pharma has emerged as a potential threat to BioMarin's Voxzogo, mentioning period 3 develo...
.Though Alkeus Pharmaceuticals' dental eye illness possession fell short to significantly reduce geo...
.Along with a trio of biotechs striking the Nasdaq on Friday, it was actually effortless to skip a s...
.Invulnerable checkpoint inhibitors are the superheroes of cancer treatment. Medications like Bristo...
.Accept to recently's Chutes & Ladders, our summary of significant management hirings, shootings ...
.Regeneron is back along with long-lasting follow-up for its LAG-3 prevention as well as PD-1 inhibi...
.AstraZeneca has actually shared a very early examine the functionality of its internal antibody-dru...
.After introducing a stage 3 launch based upon good midstage results, iTeos and also GSK are finally...
.The FDA needs to be actually more open and also collective to release a surge in approvals of rare ...
.It is actually an extraordinarily occupied Friday for biotech IPOs, with Zenas BioPharma, MBX and B...
.Atea Pharmaceuticals' antiviral has fallen short an additional COVID-19 trial, but the biotech stil...
.Neurocrine Biosciences' schizophrenia program pivot has actually stopped working. The biotech was a...
.Sanofi has actually created an overdue access to the radioligand gathering, paying out 100 million ...